INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $24,000 | +500.0% | 190 | +280.0% | 0.00% | – |
Q2 2019 | $4,000 | -33.3% | 50 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +20.0% | 50 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | +50.0% | 50 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | +33.3% | 50 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q3 2017 | $3,000 | -50.0% | 50 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | +20.0% | 50 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -37.5% | 50 | 0.0% | 0.00% | – |
Q3 2016 | $8,000 | +14.3% | 50 | 0.0% | 0.00% | – |
Q2 2016 | $7,000 | -50.0% | 50 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | +100.0% | 50 | 0.0% | 0.00% | – |
Q4 2015 | $7,000 | -12.5% | 50 | 0.0% | 0.00% | – |
Q3 2015 | $8,000 | -33.3% | 50 | 0.0% | 0.00% | – |
Q2 2015 | $12,000 | -14.3% | 50 | 0.0% | 0.00% | – |
Q1 2015 | $14,000 | +75.0% | 50 | 0.0% | 0.00% | – |
Q4 2014 | $8,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |